-
The Pennant Group recently reported its fourth-quarter and full-year 2025 results, with sales rising to US$289.32 million for the quarter and US$947.71 million for the year, alongside higher net income and earnings per share, and issued 2026 revenue guidance in the range of US$1.13 billion to US$1.17 billion.
-
Management’s 2026 outlook, including adjusted EBITDA guidance below analyst expectations despite record growth and large acquisitions such as Signature Healthcare at Home and former UnitedHealth/Amedisys sites, has shifted investor focus toward how efficiently Pennant can integrate and optimize its expanded footprint.
-
We’ll now examine how Pennant’s record 2025 results and integration-focused 2026 guidance shape and potentially recalibrate its investment narrative.
Uncover the next big thing with 31 elite penny stocks that balance risk and reward.
Pennant’s story rests on a simple idea: demand for home health, hospice, and senior living can support a larger, more efficient care platform over time. The key short term catalyst now is how effectively management can integrate the recent Signature Healthcare at Home and UnitedHealth/Amedisys acquisitions into a coherent, profitable network. The biggest near term risk is that integration and cost control fall short just as reimbursement and labor pressures remain elevated, and the latest guidance makes that execution test more visible rather than materially changing it.
The most relevant announcement here is Pennant’s 2026 outlook, which pairs record 2025 revenue of US$947.71 million with guidance for US$1.13 billion to US$1.17 billion in 2026 revenue and adjusted EBITDA below analyst expectations. That combination sharpened attention on whether Pennant’s acquisition heavy growth is translating into the kind of operating leverage investors had hoped for, and how quickly the expanded Southeast footprint can contribute to earnings in a way that supports the longer term catalysts tied to demographics and home based care.
Yet behind those strong 2025 numbers, investors should be aware that integration missteps or slower than planned operational improvement across the new markets could…
Read the full narrative on Pennant Group (it’s free!)
Pennant Group’s narrative projects $1.2 billion revenue and $59.3 million earnings by 2028. This requires 13.6% yearly revenue growth and about a $32.5 million earnings increase from $26.8 million today.
Uncover how Pennant Group’s forecasts yield a $37.50 fair value, a 11% upside to its current price.
